Mode
Text Size
Log in / Sign up

BCI-based interventions improve FMA-UE scores in patients with stroke and poststroke hemiplegiaBrain-computer interfaces show promise for stroke recovery and mobility

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that BCI-based interventions, especially BCI-MI-TEAS, improve motor scores in stroke patients, though evidence is exploratory.

This network meta-analysis evaluated the efficacy of various noninvasive brain-computer interface (BCI) interventions for patients with stroke and poststroke hemiplegia. The study included a total population of 2906 patients. The interventions analyzed included BCI-motor imagery-transcutaneous electrical acupoint stimulation (BCI-MI-TEAS), BCI-MI-end-effector robots, and BCI-MI-exoskeleton robots, all compared against various control groups.

The primary outcome measured was the Fugl-Meyer Assessment of Upper Extremity (FMA-UE). Results indicated that BCI-based interventions improved FMA-UE scores compared to control groups, with a mean difference (MD) of 5.33 (95% CI 4.28 to 6.38; 95% PI -1.76 to 12.43). Within this category, BCI-MI-TEAS demonstrated the highest SUCRA of 95.5%.

Secondary outcomes included the Action Research Arm Test (ARAT), Wolf Motor Function Test (WMFT), and Modified Barthel Index (MBI). For the ARAT, BCI-based interventions showed an improvement with an MD of 5.26 (95% CI 3.90 to 6.62; 95% PI 0.41 to 10.11). Both BCI-MI-end-effector robots combined with tDCS (86.3%) and BCI-MI-TEAS (86.3%) achieved the highest SUCRA for this outcome. For the WMFT, BCI-based interventions showed an improvement with an MD of 7.25 (95% CI 5.06 to 9.44; 95% PI 0.71 to 13.79), where the BCI-MI-exoskeleton robot had the highest SUCRA of 92.7%. For the MBI, BCI-based interventions showed an improvement with an MD of 8.18 (95% CI 6.04 to 10.32; 95% PI -1.87 to 18.23); BCI-MI-TEAS (85.3%) and BCI-MI-exoskeleton robot (81.7%) ranked highest.

Safety and tolerability data were not reported in the study. Therefore, specific adverse event rates, serious adverse events, or discontinuation rates for these BCI-based interventions are not available in the current data set.

These results provide a comparative framework for BCI-based technologies in stroke rehabilitation. While the study identifies specific advantages for different modalities, such as BCI-MI-TEAS for overall performance across body functions and BCI-MI-exoskeleton robots for activities of daily living, the evidence is currently characterized by low to moderate certainty and substantial heterogeneity. These factors suggest that while the trends are positive, the results remain exploratory.

Methodological limitations include the substantial heterogeneity across the included studies and the resulting low to moderate evidence certainty. These factors necessitate a cautious interpretation of the specific superiority of one BCI modality over another.

Clinically, these findings suggest that BCI-based interventions, particularly BCI-MI-TEAS, may be effective for improving upper extremity motor function and activities of daily living in patients with poststroke hemiplegia. However, the specific choice of device may depend on the clinical goal, such as fine motor dexterity versus general mobility. Questions remain regarding the long-term durability of these improvements and the optimal timing for introducing BCI-based interventions into standard rehabilitation protocols.

How this fits prior evidence

How this fits prior evidence: This study addresses a gap in noninvasive technological interventions for stroke recovery. While previous evidence noted that specific traditional Chinese medicine formulations show varied outcomes in patients with ischemic stroke, this study provides a different perspective on technological interventions. It does not directly relate to the findings regarding Tai Chi, cardiovascular risk markers, the mothership strategy, or the efficacy of thrombectomy for MDVO.

Living with the aftermath of a stroke can be incredibly challenging. For many survivors, the most difficult hurdle is regaining movement in a weakened arm or hand. This loss of mobility can make simple daily tasks, like reaching for a cup or getting dressed, feel like impossible mountains to climb. New research is looking into how technology can bridge this gap and help patients regain their independence.

Researchers looked at a large collection of data involving over 2,900 patients who experienced hemiplegia, which is the weakness or paralysis of one side of the body, following a stroke. They compared different types of brain-computer interface (BCI) treatments against standard care. A brain-computer interface is a system that allows a person to interact with a device using brain signals. These specific treatments included combinations of BCI with motor imagery (imagining movement), electrical stimulation, and robotic systems like end-effector robots or exoskeleton suits.

The results showed that these BCI-based interventions performed better than standard control groups across several measures of physical ability. For example, patients using BCI combined with electrical stimulation showed significant improvements in upper limb motor function. Other combinations, such as BCI with exoskeleton robots, showed strong results in helping patients perform activities of daily living. Specifically, the study found that different BCI setups were effective at improving various scores related to arm movement, fine motor skills, and overall daily independence.

While these results are encouraging, it is important to keep expectations realistic. The researchers noted that the evidence for these treatments currently has a low to moderate level of certainty. This means that while the data looks promising, there is still a lot of variety in how different patients respond to the technology. Because the findings are still in the exploratory phase, we cannot say exactly how these tools will work for every individual just yet. For patients today, this means that while these technologies are not yet a standard replacement for traditional physical therapy, they represent a promising path forward. These tools could eventually become powerful additions to a rehabilitation plan, offering new ways to retrain the brain and body after a stroke. For now, these findings highlight the potential of combining high-tech robotics and brain signals to help people regain their strength.

What this means for you:
Brain-computer interfaces show promise for improving arm movement and daily tasks after a stroke.

Study Details

Study typeSystematic review
Sample sizen = 2,906
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: Noninvasive brain-computer interface (BCI)-based interventions show promise for poststroke motor recovery. However, the intrinsic complexity of BCI-based interventions limits the determination of their comparative efficacy. OBJECTIVE: Guided by the International Classification of Functioning, Disability and Health framework, this review evaluated the effectiveness of BCI-based interventions in poststroke upper limb rehabilitation and identify the optimal intervention. METHODS: We searched PubMed, Cochrane Library, EBSCOhost, Web of Science, Embase, Wiley Online Library,CNKI, Wanfang, VIP, and SinoMed through July 2026. Randomized controlled trials (RCTs) assessing BCI-based interventions for poststroke upper limb rehabilitation were included. Outcomes were body functions and structures (Fugl-Meyer Assessment of Upper Extremity [FMA-UE]) and activities and participation (Action Research Arm Test [ARAT], Wolf Motor Function Test [WMFT], and Modified Barthel Index [MBI]). Risk of bias was assessed using Cochrane RoB 2, and evidence quality was graded using the Grading of Recommendations, Assessment, Development, and Evaluation framework. We used pairwise meta-analyses to evaluate the overall effectiveness of BCI-based interventions vs controls and network meta-analysis to compare the interventions. RESULTS: Seventy-two RCTs involving 2906 patients with stroke were included, evaluating 12 BCI-based interventions. Pairwise meta-analyses demonstrated that, compared with control groups, BCI-based interventions improved FMA-UE (mean difference [MD] 5.33, 95% CI 4.28 to 6.38; 95% prediction interval [PI] -1.76 to 12.43), ARAT (MD 5.26, 95% CI 3.90 to 6.62; 95% PI 0.41 to 10.11), WMFT (MD 7.25, 95% CI 5.06 to 9.44; 95% PI 0.71 to 13.79), and MBI (MD 8.18, 95% CI 6.04 to 10.32; 95% PI -1.87 to 18.23). Network meta-analysis revealed that BCI-motor imagery-transcutaneous electrical acupoint stimulation (BCI-MI-TEAS) achieved the highest surface under the cumulative ranking curve (SUCRA; 95.5%) in improving FMA-UE. For ARAT, BCI-MI-end-effector robots and transcranial direct current stimulation (tDCS; 86.3%) alongside BCI-MI-TEAS (86.3%) yielded the highest SUCRA. BCI-MI-exoskeleton robot showed the highest SUCRA for WMFT (92.7%), whereas BCI-MI-TEAS (85.3%) and BCI-MI-exoskeleton robot (81.7%) ranked highest for MBI. The evidence quality ranged from very low to high across these interventions. CONCLUSIONS: This study represents the first network meta-analysis comparing the efficacy of different BCI-based interventions. Unlike previous reviews, interventions were categorized by experimental paradigms, external feedback devices, and adjunctive noninvasive brain stimulation, to enable clinically meaningful comparisons. Overall, BCI-based interventions significantly improved poststroke upper limb rehabilitation. Among evaluated interventions, BCI-MI-TEAS demonstrated the most performance across body functions, structures, and activities and participation, whereas BCI-MI-end-effector robot + tDCS showed advantages for fine motor dexterity and BCI-MI-exoskeleton robot improved activities of daily living.Given low to moderate evidence certainty and substantial heterogeneity, these findings remain exploratory. High-quality trials are needed to establish the clinical utility of these interventions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.